![]() |
市場調查報告書
商品編碼
1675346
2025 年至 2033 年產前及新生兒基因檢測市場報告(按產品類型、篩檢、疾病、最終用戶和地區)Prenatal and Newborn Genetic Testing Market Report by Product Type, Screening, Disease, End User, and Region 2025-2033 |
2024IMARC Group全球產前和新生兒基因檢測市場規模達到 67 億美元。隨著先進診斷和篩檢設備的需求不斷成長、醫療行業蓬勃發展以及新生兒先天畸形和遺傳異常患病率不斷上升,市場佔有率正在穩步成長。
主要市場促進因素:產前和新生兒基因檢測的需求不斷增加以及醫療行業的不斷發展,推動了產前和新生兒基因檢測市場的成長。
主要市場趨勢:主要趨勢包括產前和新生兒護理中擴大採用基因檢測來實現個人化醫療。這對產前和新生兒基因檢測市場趨勢產生了積極影響。
地理趨勢:由於接受基因篩檢的孕婦數量不斷增加,北美引領產前和新生兒基因檢測市場需求。亞太地區的產前和新生兒基因檢測市場預計也會成長。
競爭格局:雅培實驗室和華大基因集團是推動產前和新生兒基因檢測市場收入的一些產前和新生兒基因檢測市場公司。
挑戰和機會:挑戰包括道德和法律方面的考慮。產前和新生兒基因檢測市場最近的機會在於人工智慧和機器學習技術的融合。
嬰兒遺傳病患疾病率高
子宮內的胎兒受到幾種遺傳疾病的影響。這些遺傳疾病的遺傳模式在決定復發的可能性和懷孕期間帶來的風險方面發揮作用。如果父母一方患有染色體異常、家族有遺傳病史或另一方有遺傳疾病,則其所生嬰兒患遺傳疾病的幾率會更大。嬰兒更容易受到遺傳性疾病的影響。此外,這些疾病也是造成全球嬰兒死亡的罪魁禍首。例如,世界衛生組織預測,全球有790萬個嬰兒出生時患有基因異常。因此,嬰兒遺傳疾病的高盛行率正在推動產前和新生兒基因檢測市場前景。
技術進步
產前和新生兒基因檢測市場報告的成長主要歸功於技術的進步。非侵入性產前檢測和下一代定序等許多重大進步提高了篩檢程序的質量,同時保持了保證準確性和改善結果的安全要求。此外,強烈建議醫療保健產業使用這些創新來檢測和識別更大範圍的基因異常。它還確保準父母做出最有利於未出生孩子的健康和安全的決策。此外,我們也做出了重大改進,提高了轉換的真實性和可靠性。
提高認知和需求
由於人們對產前和新生兒基因檢測的認知和需求不斷成長,產前和新生兒基因檢測市場概況經歷了令人難以置信的擴張。如今,早期基因篩檢的價值越來越被人們所認知,包括準父母和醫療保健專業人士。市場對創新的需求也隨之增加。透過這項創新,人們可以了解仍然存在的基因異常,並及時採取預防措施,以降低嬰兒生命的風險。為了未出生孩子的健康和安全,懷孕的父母有能力做出最好的決定。由於需求不斷成長,測試服務吸引了來自世界各地的研究人員和投資者。
The global prenatal and newborn genetic testing market size reached USD 6.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.3 Billion by 2033, exhibiting a growth rate (CAGR) of 11.04% during 2025-2033. The market share is experiencing steady growth driven by the growing demand for advanced diagnostic and screening devices, the thriving medical industry, and the rising prevalence of congenital malformations and genetic abnormalities in newborn babies.
Major Market Drivers: The increasing demand for prenatal and newborn genetic testing and a growing medical industry are driving the prenatal and newborn genetic testing market growth.
Key Market Trends: Key trends include increasing adoption of genetic testing for personalized medicine in prenatal and newborn care. This is positively impacting the prenatal and newborn genetic testing market trends.
Geographical Trends: North America leads the prenatal and newborn genetic testing market demand due to the growing number of pregnant women undergoing genetic screening. The prenatal and newborn genetic testing market forecast for Asia Pacific is also expected to witness growth.
Competitive Landscape: Abbott Laboratories and BGI Group are some of the prenatal and newborn genetic testing market companies driving the prenatal and newborn genetic testing market revenue.
Challenges and Opportunities: Challenges include ethical and legal considerations. The prenatal and newborn genetic testing market recent opportunities lie in the integration of AI and ML technologies.
High Prevalence of Genetic Diseases in Infants
The fetuses in the womb are affected by several genetic disorders. The inheritance pattern of these genetic illnesses has a role in determining both the chance of recurrence and the risk they pose during pregnancy. Babies that have a parent with a chromosomal anomaly, a family history of genetic disorders, or another kid who has a genetic disease are more likely to have genetic diseases. Infants are significantly more likely to be affected by hereditary disorders. Furthermore, these illnesses are to blame for infant mortality worldwide. For example, the World Health Organization predicted that 7.9 million babies worldwide are born with genetic abnormalities. Therefore, the high prevalence of genetic diseases in infants is driving the prenatal and newborn genetic testing market outlook.
Technological advancements
The growth of the prenatal and newborn genetic testing market report is mostly due to advancements in technology. A number of significant advancements, such as non-invasive prenatal testing and next-generation sequencing, have improved the quality of the screening procedure while maintaining safety requirements that guarantee accuracy and improved outcomes. Furthermore, it is highly recommended that the healthcare industry use these innovations to detect and identify a larger range of genetic abnormalities. It also makes sure that the expectant parents decide what's best for the health and safety of their unborn child. Furthermore, a significant improvement has been made, which raises the transformations' authenticity and dependability.
Increasing awareness and demand
The prenatal and newborn genetic testing market overview has experienced an incredible expansion due to the growing awareness and demand for prenatal and newborn genetic testing. These days, the value of early genetic screening is being recognized by more people, including expectant parents and healthcare professionals. The market's need for innovation has increased as a result of this. By using this innovation, a person can learn about genetic abnormalities that are still present and take timely preventative action to reduce the risk to the lives of the babies. With regard to the health and safety of their unborn child, pregnant parents are capable of making the best decisions. Researchers and investors from all over the world have been drawn to the testing services due to their increasing demand.
Consumables account for the majority of the market share
Consumables like testing kits and reagents are fueling the prenatal and newborn genetic testing market recent developments. These kits are really important for checking if babies have any genetic problems before they're born or right after they're born. Also, new technology is making these tests better and easier to do. As more people want these tests, the market for the supplies needed for them is growing, too. Doctors need these supplies to offer good genetic testing services. So, these supplies are a big part of why prenatal and newborn genetic testing is becoming more popular and helpful for families.
Non-invasive prenatal testing holds the largest share of the industry
NIPT is the best way to check babies before they're born. It doesn't require taking samples from the womb. It depends on simple blood tests from the mother. This method is safer and more comfortable. It offers accurate results in detecting genetic conditions like Down syndrome. It doesn't involve any complications associated with invasive techniques. Due to these benefits, more expecting parents are opting for NIPT. It's the top choice for prenatal testing as it's convenient, safe, and gives reliable results.
Downs syndrome represents the leading market segment
The largest prenatal and newborn genetic testing market recent price is held by Down syndrome testing. An additional copy of chromosome 21 causes this disorder. It is essential for aspiring parents to get tested for Down syndrome in order to plan for any particular care their child may require. The accuracy and accessibility of Down syndrome diagnostics have increased due to technological breakthroughs. Pregnant women are choosing these tests more frequently in order to protect the health of their unborn child. Furthermore, these examinations are advised by medical professionals as standard prenatal care. There is a large demand for testing, which has led to its dominance in the genetic testing market.
Hospital represents the leading market segment
Hospitals are at the top of the market. They are essential in the provision of many medical services, such as genetic testing. Patients seeking genetic testing services prefer hospitals as they are dependable and convenient. Hospitals provide accurate testing and appropriate counselling for patients and their families since they have highly qualified staff and modern facilities. Hospitals also frequently work with medical specialists to provide proper care. People are drawn to hospitals due to their reputation for providing high-quality healthcare services. They thereby lead the market share, confirming their status as the main suppliers of genetic testing services.
North America leads the market, accounting for the largest prenatal and newborn genetic testing market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
With a sizable portion of the global market for prenatal and newborn genetic testing, North America currently has a prominent position. The prenatal and newborn genetic testing market has strengthened its position in the region due to a significant number of companies operating in the diagnostics and screening sectors, in addition to the region's increased prevalence of genetic abnormalities and a huge pool of highly aware parents. Also, an increasing number of expecting mothers in this area are having their genetics screened, which supports the market's expansion. The strong purchasing power and growing public knowledge are anticipated to fuel market expansion. For example, March 21st is designated as World Down Syndrome Day each year to raise awareness of the diagnosis and care of individuals with Down syndrome.
The market for prenatal and newborn genetic testing is expanding rapidly due to the major companies' creativity, innovation, teamwork, and cutting-edge technology. Some of the biggest businesses are constantly working to improve the testing process's quality and safety. The key players are primarily concerned with growing the test panels' capacity to screen for and identify genetic diseases. Additionally, the market for prenatal and newborn genetic testing is expanding at an even faster rate with the help of technological advancements. Furthermore, accessibility and flexibility are guaranteed through partnerships with regulatory bodies and the healthcare industry. Both the expecting parents and their newborns greatly benefit from prenatal and newborn genetic testing.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.